In fact, application of an aromatase inhibitor eliminates CA LTP generated by theta-burst stimulation in intact female neurons, but not male or OVX animals, posing a potentially serious concern for women using aromatase inhibitors for therapeutic treatment of breast cancer [146]. Here, CYP19A1 is linked to breast carcinoma.